INSIGHTS ON CLINICAL TRIAL PARTNERING

• How To Unlock The Secret To Repeatable, Scalable Low Turnover

  Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

• 2025 Clinical Trial Payment Tax Implications Explained

  Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.

• Ergomed's Solutions To The Challenges of Oncology Trials

  Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

• Is Your Help Desk A Lifeline Or A Landline?

  A help desk should accelerate trial success, not create delays. Discover how proactive support and modern tools turn help desks into strategic assets that improve efficiency and reduce risk.

• Accelerating Parkinson's Disease Clinical Research Through CHDR's Monocentre Recruitment Capabilities

  1/14/2026

  Centralized PD trials reduce variability, accelerate enrolment, and enable genetic stratification for targeted therapies. This streamlined model delivers high-quality data and faster timelines, helping sponsors move confidently from early-phase research to late-stage development.

• CRO Solutions Expo: Clinical Research Is A Delicate Ecosystem

  11/21/2025

  Elevate your complex oncology program by partnering with a team that delivers transparent communication, deep expertise, and the focused attention emerging and midsized biotechs need to succeed.

• Paperless Online Remote Source Document Verification

  2/2/2026

  Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.

• Best Practices For Internal Quality Audits In Life Sciences

  3/14/2025

  Discover why internal quality audits are vital in the life sciences sector to ensure regulatory compliance, mitigate risks, and maintain high standards of product quality and patient safety amidst evolving challenges.

• Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them

  10/21/2025

  Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.